PMHS logo

Polomar Health Services, Inc. Stock Price

OTCPK:PMHS Community·US$2.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PMHS Share Price Performance

US$0.094
-0.29 (-75.29%)
US$0.094
-0.29 (-75.29%)
Price US$0.094

PMHS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk and overvalued.

5 Risks
1 Reward

Polomar Health Services, Inc. Key Details

US$1.6m

Revenue

US$641.8k

Cost of Revenue

US$1.0m

Gross Profit

US$11.3m

Other Expenses

-US$10.3m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.37
61.08%
-622.70%
-65.8%
View Full Analysis

About PMHS

Founded
n/a
Employees
7
CEO
Terrence Tierney
WebsiteView website
polomarsp.com

Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

Recent PMHS News & Updates

Recent updates

No updates